Cutaneous melanoma: Family screening and genetic testing

Dermatologic Therapy

Volumn 19, Issue 1, 2006, Pages 1-8

  Niendorf, Kristin B ^a   Tsao, Hensin ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b Department of Dermatology ^*  (United States)

Author keywords

Cutaneous melanoma; Dysplastic melanocytic nevi; Genetic predisposition testing; Hereditary cancer syndrome; Melanoma; Prevention

Indexed keywords

ARF PROTEIN; CA 19-9 ANTIGEN; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6; PROTEIN MDM2; PROTEIN P16; REGULATOR PROTEIN; RETINOBLASTOMA PROTEIN;

CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER RISK; CANCER SCREENING; CHROMOSOMAL LOCALIZATION; DISEASE PREDISPOSITION; ENDOSCOPIC ECHOGRAPHY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENVIRONMENTAL FACTOR; FAMILIAL CANCER; FAMILY HISTORY; GENE MUTATION; GENETIC ANALYSIS; GENETIC COUNSELING; GENETIC SCREENING; HIGH RISK PATIENT; HIGH RISK POPULATION; HUMAN; MELANOMA; NEVUS; ONSET AGE; PANCREAS CANCER; PATIENT EDUCATION; PATIENT IDENTIFICATION; PHENOTYPE; RADIATION EXPOSURE; REVIEW; RISK ASSESSMENT; VERTICAL TRANSMISSION;

ALGORITHMS; FEMALE; GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GENETIC TECHNIQUES; HEALTH EDUCATION; HUMANS; MALE; MELANOMA; PEDIGREE; PREVALENCE; RISK ASSESSMENT; SKIN NEOPLASMS; UNITED STATES;

EID: 33645091229     PISSN: 13960296     EISSN: 15298019     Source Type: Journal    
DOI: 10.1111/j.1529-8019.2005.00050.x     Document Type: Review

References (73)

1. Jemal A Murray T Ward E et al. Cancer statistics, 2005 CA Cancer J Clin 2005 55 10 30
2. Tucker MA Goldstein AM Melanoma etiology: where are we? Oncogene 2003 22 3042 3052
3. Armstrong BK Kricker A The epidemiology of UV-induced skin cancer J Photochem Photobiol B 2001 63 8 18
4. Ford D Bliss JM Swerdlow AJ et al. Risk of cutaneous melanoma associated with a family history of the disease. The International Melanoma Analysis Group (IMAGE) Int J Cancer 1995 62 377 381
5. Goldstein AM Tucker MA Genetic epidemiology of familial melanoma Dermatol Clin 1995 13 605 612
6. Goldstein AM Tucker MA Genetic epidemiology of cutaneous melanoma: a global perspective Arch Dermatol 2001 137 1493 1496
7. Hayward NK Genetics of melanoma predisposition Oncogene 2003 22 3053 3062
8. Clark WH Jr. Reimer RR Greene M Ainsworth AM Mastrangelo MJ Origin of familial malignant melanomas from heritable melanocytic lesions: the B-K mole syndrome Arch Dermatol 1978 114 723 728
9. Lynch HT Frichot BC III. Lynch JF Familial atypical multiple mole-melanoma syndrome J Med Genet 1978 15 352 356
10. Elder DE Green MH Guerry Dt Kraemer KH Clark WH Jr. The dysplastic nevus syndrome: our definition Am J Dermatopathol 1982 4 455 460
11. NIH Consensus Conference. Diagnosis and treatment of early melanoma JAMA 1992 268 1314 1319
12. Kopf AW Friedman RJ Rigel DS Atypical mole syndrome J Am Acad Dermatol 1990 22 117 118
13. Kefford RF Newton Bishop JA Bergman W Tucker MA Counseling and DNA testing for individuals perceived to be genetically predisposed to melanoma: a consensus statement of the Melanoma Genetics Consortium J Clin Oncol 1999 17 3245 3251
14. Kefford R Bishop JN Tucker M et al. Genetic testing for melanoma Lancet Oncol 2002 3 653 654
15. Hansen CB Wadge LM Lowstuter K Boucher K Leachman SA Clinical germline genetic testing for melanoma Lancet Oncol 2004 5 314 319
16. Tsao H Sober AJ Niendorf KB Zembowicz A Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 7-2004. A 48-year-old woman with multiple pigmented lesions and a personal and family history of melanoma N Engl J Med 2004 350 924 932
17. Bahuau M Vidaud D Jenkins RB et al. Germline deletion involving the INK4 locus in familial proneness to melanoma and nervous system tumors Cancer Res 1998 58 2298 2303
18. Petronzelli F Sollima D Coppola G Martini-Neri ME Neri G Genuardi M CDKN2A germline splicing mutation affecting both p16 (ink4) and p14 (arf) RNA processing in a melanoma/neurofibroma kindred Genes Chromosomes Cancer 2001 31 398 401
19. Randerson-Moor JA Harland M Williams S et al. A germline deletion of P14(ARF) but not CDKN2A in a melanoma-neural system tumour syndrome family Hum Mol Genet 2001 10 55 62
20. Hewitt C Lee Wu C Evans G et al. Germline mutation of ARF in a melanoma kindred Hum Mol Genet 2002 11 1273 1279
21. Rizos H Darmanian AP Holland EA Mann GJ Kefford RF Mutations in the INK4a/ARF melanoma susceptibility locus functionally impair p14ARF J Biol Chem 2001 276 41424 41434
22. Gruis NA Sandkuijl LA van der Velden PA Bergman W Frants RR CDKN2 explains part of the clinical phenotype in Dutch familial atypical multiple-mole melanoma (FAMMM) syndrome families Melanoma Res 1995 5 169 177
23. Borg A Johansson U Johannsson O et al. Novel germline p16 mutation in familial malignant melanoma in southern Sweden Cancer Res 1996 56 2497 2500
24. MacKie RM Andrew N Lanyon WG Con nor JM CDKN2A germline mutations in U.K. patients with familial melanoma and multiple primary melanomas J Invest Dermatol 1998 111 269 272
25. Liu L Dilworth D Gao L et al. Mutation of the CDKN2A 5′ UTR creates an aberrant initiation codon and predisposes to melanoma Nat Genet 1999 21 128 132
26. Ciotti P Struewing JP Mantelli M et al. A single genetic origin for the G101W CDKN2A mutation in 20 melanoma-prone families Am J Hum Genet 2000 67 311 319
27. Goldstein AM Liu L Shennan MG Hogg D Tucker MA Struewing JP A common founder for the V126D CDKN2A mutation in seven North American melanoma-prone families Br J Cancer 2001 85 527 530
28. Aitken J Welch J Duffy D et al. CDKN2A variants in a population-based sample of Queensland families with melanoma J Natl Cancer Inst 1999 91 446 452
29. Goldstein AM Tucker MA Screening for CDKN2A mutations in hereditary melanoma J Natl Cancer Inst 1997 89 676 677
30. Monzon J Liu L Brill H et al. CDKN2A mutations in multiple primary melanomas N Engl J Med 1998 338 879 887
31. Hashemi J Platz A Ueno T Stierner U Ringborg U Hansson J CDKN2A germ-line mutations in individuals with multiple cutaneous melanomas Cancer Res 2000 60 6864 6867
32. Auroy S Avril MF Chompret A et al. Sporadic multiple primary melanoma cases: CDKN2A germline mutations with a founder effect Genes Chromosomes Cancer 2001 32 195 202
33. Youl P Aitken J Hayward N et al. Melanoma in adolescents: a case-control study of risk factors in Queensland, Australia Int J Cancer 2002 98 92 98
34. Tsao H Zhang X Kwitkiwski K Finkelstein DM Sober AJ Haluska FG Low prevalence of germline CDKN2A and CDK4 mutations in patients with early-onset melanoma Arch Dermatol 2000 136 1118 1122
35. Bartsch DK Sina-Frey M Lang S et al. CDKN2A germline mutations in familial pancreatic cancer Ann Surg 2002 236 730 737
36. Bishop DT Demenais F Goldstein AM et al. Geographical variation in the penetrance of CDKN2A mutations for melanoma J Natl Cancer Inst 2002 94 894 903
37. Borg A Sandberg T Nilsson K et al. High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families J Natl Cancer Inst 2000 92 1260 1266
38. Ciotti P Strigini P Bianchi-Scarra G Familial melanoma and pancreatic cancer N Engl J Med 1996 334 469 470
39. Moskaluk CA Hruban H Lietman A et al. Novel germline p16(INK4) allele (Asp145Cys) in a family with multiple pancreatic carcinomas. Mutations in brief no. 148. Online Hum Mutat 1998 12 70
40. Soufir N Avril MF Chompret A et al. Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France Hum Mol Genet 1998 7 209 216
41. Ghiorzo P Ciotti P Mantelli M et al. Characterization of Ligurian melanoma families and risk of occurrence of other neoplasia Int J Cancer 1999 83 441 448
42. INK4 mutations N Engl J Med 1995 333 970 974
43. Lal G Liu L Hogg D Lassam NJ Redston MS Gallinger S Patients with both pancreatic adenocarcinoma and melanoma may harbor germline CDKN2A mutations Genes Chromosomes Cancer 2000 27 358 361
44. Lal G Liu G Schmocker B et al. Inherited predisposition to pancreatic adenocarcinoma: role of family history and germline p16, BRCA1, and BRCA2 mutations Cancer Res 2000 60 409 416
45. Lynch HT Brand RE Hogg D et al. Phenotypic variation in eight extended CDKN2A germline mutation familial atypical multiple mole melanoma-pancreatic carcinoma-prone families: the familial atypical mole melanoma-pancreatic carcinoma syndrome Cancer 2002 94 84 96
46. Vasen HF Gruis NA Frants RR van Der Velden PA Hille ET Bergman W Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma associated with a specific 19 deletion of p16 (p16-Leiden) Int J Cancer 2000 87 809 811
47. Goldstein AM Struewing JP Fraser MC Smith MW Tucker MA Prospective risk of cancer in CDKN2A germline mutation carriers J Med Genet 2004 41 421 424
48. Goldstein AM Struewing JP Chidambaram A Fraser MC Tucker MA Genotype-phenotype relationships in U.S. melanoma-prone families with CDKN2A and CDK4 mutations J Natl Cancer Inst 2000 92 1006 1010
49. Bergman W Gruis N Familial melanoma and pancreatic cancer N Engl J Med 1996 334 471 472
50. INK4a binding domain of CDK4 in familial melanoma Nature Genet 1996 12 97 99
51. Gillanders E Hank Juo SH Holland EA et al. Localization of a novel melanoma susceptibility locus to 1p22 Am J Hum Genet 2003 73 301 313
52. Cancer risks in BRCA2 mutation carriers. The Breast Cancer Linkage Consortium J Natl Cancer Inst 1999 91 1310 1316
53. Sinilnikova OM Egan KM Quinn JL et al. Germline BRCA2 sequence variants in patients with ocular melanoma Int J Cancer 1999 82 325 328
54. Iscovich J Abdulrazik M Cour C Fischbein A Pe'er J Goldgar DE Prevalence of the BRCA2 6174 del T mutation in Israeli uveal melanoma patients Int J Cancer 2002 98 42 44
55. Scott RJ Vajdic CM Armstrong BK et al. BRCA2 mutations in a population-based series of patients with ocular melanoma Int J Cancer 2002 102 188 191
56. Box NF Wyeth JR O'Gorman LE Martin NG Sturm RA Characterization of melanocyte-stimulating hormone receptor variant alleles in twins with red hair Hum Mol Genet 1997 6 1891 1897
57. Palmer JS Duffy DL Box NF et al. Melanocortin-1 receptor polymorphisms and risk of melanoma: is the association explained solely by pigmentation phenotype? Am J Hum Genet 2000 66 176 186
58. Bastiaens M ter Huurne J Gruis N et al. The melanocortin-1-receptor gene is the major freckle gene Hum Mol Genet 2001 10 1701 1708
59. Sturm RA Duffy DL Box NF et al. Genetic association and cellular function of MC1R variant alleles in human pigmentation Ann NY Acad Sci 2003 994 348 358
60. Valverde P Healy E Sikkink S et al. The Asp84Glu variant of the melanocortin 1 receptor (MC1R) is associated with melanoma Hum Mol Genet 1996 5 1663 1666
61. Valverde P Healy E Jackson I Rees JL Thody AJ Variants of the melanocyte-stimulating hormone receptor gene are associated with red hair and fair skin in humans Nat Genet 1995 11 328 330
62. Box NF Duffy DL Chen W et al. MC1R genotype modifies risk of melanoma in families segregating CDKN2A mutations Am J Hum Genet 2001 69 765 773
63. van der Velden PA Sandkuijl LA Bergman W et al. Melanocortin-1 receptor variant R151C modifies melanoma risk in Dutch families with melanoma Am J Hum Genet 2001 69 774 779
64. Koh HK Norton LA Geller AC et al. Evaluation of the American Academy of Dermatology's national skin cancer early detection and screening program J Am Acad Dermatol 1996 34 971 978
65. Masri GD Clark WH Jr. Guerry Dt Halpern A Thompson CJ Elder DE Screening and surveillance of patients at high risk for malignant melanoma result in detection of earlier disease J Am Acad Dermatol 1990 22 1042 1048
66. Carli P De Giorgi V Palli D et al. Dermatologist detection and skin self-examination are associated with thinner melanomas: results from a survey of the Italian Multidisciplinary Group on Melanoma Arch Dermatol 2003 139 607 612
67. Parker JF Florell SR Alexander A DiSario JA Shami PJ Leachman SA Pancreatic carcinoma surveillance in patients with familial melanoma Arch Dermatol 2003 139 1019 1025
68. Brentnall TA Bronner MP Byrd DR Haggitt RC Kimmey MB Early diagnosis and treatment of pancreatic dysplasia in patients with a family history of pancreatic cancer Ann Intern Med 1999 131 247 255
69. Rulyak SJ Kimmey MB Veenstra DL Brentnall TA Cost-effectiveness of pancreatic cancer screening in familial pancreatic cancer kindreds Gastrointest Endosc 2003 57 23 29
70. Marrett LD King WD Walter SD From L Use of host factors to identify people at high risk for cutaneous malignant melanoma CMAJ 1992 147 445 453
71. Bliss JM Ford D Swerdlow AJ et al. Risk of cutaneous melanoma associated with pigmentation characteristics and freckling: systematic overview of 10 case-control studies. The International Melanoma Analysis Group (IMAGE) Int J Cancer 1995 62 367 376
72. Tucker MA Boice JD Jr. Hoffman DA Second cancer following cutaneous melanoma and cancers of the brain, thyroid, connective tissue, bone, and eye in Connecticut, 1935-82 Natl Cancer Inst Monogr 1985 68 161 189
73. Bower CP Lear JT Bygrave S Etherington D Harvey I Archer CB Basal cell carcinoma and risk of subsequent malignancies: a cancer registry-based study in southwest England J Am Acad Dermatol 2000 42 988 991